PMA P180024

Device
TransPyloric Shuttle/TransPyloric Shuttle Delivery Device
Applicant
Baronova, Inc.
PMA number
P180024
Product code
LTI
Decision date
2019-04-16
Classification
Implant, Intragastric For Morbid Obesity
Generic name
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Approval order statement
Approval for the TransPyloric Shuttle/TransPyloric Shuttle Delivery Device. The TransPyloric Shuttle/TransPyloric Shuttle Delivery Device is indicated for weight reduction in adult patients with obesity with a Body Mass Index (BMI) of 35.0-40.0 kg/m2 or a BMI of 30.0 to 34.9 kg/m2 with one or more obesity-related comorbid conditions and is intended to be used in conjunction with a diet and behavior modification program.
Summary
<a href="http://www.accessdata.fda.gov/cdrh_docs/pdf18/P180024B.pdf" target="_new">Summary of Safety and Effectiveness</a>

Current openFDA PMA Record#

Device
TransPyloric Shuttle/TransPyloric Shuttle Delivery Device
Applicant
Baronova, Inc.
PMA number
P180024
Product code
LTI
Generic name
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Decision date
2019-04-16
Decision code
APPR
Date received
2018-07-09
Approval order statement
Approval for the TransPyloric Shuttle/TransPyloric Shuttle Delivery Device. The TransPyloric Shuttle/TransPyloric Shuttle Delivery Device is indicated for weight reduction in adult patients with obesity with a Body Mass Index (BMI) of 35.0-40.0 kg/m2 or a BMI of 30.0 to 34.9 kg/m2 with one or more obesity-related comorbid conditions and is intended to be used in conjunction with a diet and behavior modification program.